- Home
- BSX vs TMO Comparison
BSX vs TMO Comparison
Compare BSX & TMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BSX
- TMO
- Stock Information
- Founded
- BSX 1979
- TMO 1956
- Country
- BSX United States
- TMO United States
- Employees
- BSX N/A
- TMO N/A
- Industry
- BSX Medical/Dental Instruments
- TMO Industrial Machinery/Components
- Sector
- BSX Health Care
- TMO Industrials
- Exchange
- BSX Nasdaq
- TMO Nasdaq
- Market Cap
- BSX 157.6B
- TMO 175.3B
- IPO Year
- BSX 1992
- TMO N/A
- Fundamental
- Price
- BSX $95.75
- TMO $525.56
- Analyst Decision
- BSX Strong Buy
- TMO Buy
- Analyst Count
- BSX 22
- TMO 16
- Target Price
- BSX $121.09
- TMO $589.13
- AVG Volume (30 Days)
- BSX 12.0M
- TMO 2.7M
- Earning Date
- BSX 10-22-2025
- TMO 10-22-2025
- Dividend Yield
- BSX N/A
- TMO 0.33%
- EPS Growth
- BSX 36.90
- TMO 7.24
- EPS
- BSX 1.68
- TMO 17.30
- Revenue
- BSX $18,494,000,000.00
- TMO $43,212,000,000.00
- Revenue This Year
- BSX $19.85
- TMO $3.54
- Revenue Next Year
- BSX $11.07
- TMO $4.83
- P/E Ratio
- BSX $56.77
- TMO $30.35
- Revenue Growth
- BSX 21.44
- TMO 2.04
- 52 Week Low
- BSX $80.64
- TMO $385.46
- 52 Week High
- BSX $109.50
- TMO $610.97
- Technical
- Relative Strength Index (RSI)
- BSX 35.90
- TMO 60.67
- Support Level
- BSX $95.38
- TMO $456.67
- Resistance Level
- BSX $98.48
- TMO $549.44
- Average True Range (ATR)
- BSX 2.35
- TMO 15.05
- MACD
- BSX 0.12
- TMO 4.04
- Stochastic Oscillator
- BSX 58.12
- TMO 73.13
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
About TMO Thermo Fisher Scientific Inc
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).